MicroPort® Neurotech was established in 2012 and a subsidiary of MicroPort Scientific Corporation (00853.HK). Having been established a solid and complete product pipelines for stroke interventional therapy, the company accumulated accesses to more than 2,300 hospitals in China and helped more than 90,000 patients. Meanwhile, MicroPort® strategically visual globally and has gradually entered the United States, Europe, South Korea, Brazil and other countries.
View more